Related Experiment Video
Updated: Sep 6, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Long Noncoding RNAs in Human Cancer and Apoptosis
İpek Erdoğan1, Osama Sweef1, Bünyamin Akgül1
1Department of Molecular Biology and Genetics, Faculty of Science, Noncoding RNA Laboratory, Izmir Institute of Technology, Izmir, Turkey.
Abstract:
Genome annotations have uncovered the production of at least one transcript from nearly all loci in the genome at some given time throughout the development. Surprisingly, many of these transcripts do not code for proteins and are relatively long in size, thus called long noncoding RNAs (lncRNAs). Next- and third-generation sequencing technologies have amassed numerous lncRNAs expressed under different phenotypic conditions, yet many remain to be functionally characterized. LncRNAs regulate gene expression by functioning as scaffold, decoy, signaling, and guide molecules both at the transcriptional and post-transcriptional levels, interacting with different types of macromolecules, such as proteins, DNA, and RNA. Here, we review the potential regulatory role of lncRNAs in apoptosis and cancer as some of these lncRNAs may have the diagnostic and therapeutic potential in cancer.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Types of RNA
RNA Performs Diverse...
The Intrinsic Apoptotic Pathway
MicroRNAs
Non-LTR Retrotransposons
The Extrinsic Apoptotic Pathway

